Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:IVTY

Invuity (IVTY) Stock Price, News & Analysis

Invuity logo

About Invuity Stock (NASDAQ:IVTY)

Advanced Chart

Key Stats

Today's Range
$7.39
$7.39
50-Day Range
N/A
52-Week Range
$2.35
$9.55
Volume
N/A
Average Volume
324,995 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive IVTY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Invuity and its competitors with MarketBeat's FREE daily newsletter.

IVTY Stock News Headlines

Ivy Bank Review: Solid High-Interest Savings
A new rule goes live in July — and the banks are quietly cashing in
A little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Street and the Big Banks… It gives them the green light to treat a certain tangible asset as equivalent to cold, hard cash. Not stocks. Not real estate. And definitely not the U.S. dollar. We're talking about something they don't want you to notice — because the fewer people who act on this, the better it is for them.
Delaware Ivy Large Cap Growth Fund A
CLPS Inc (CLPS)
Bruce A Cleveland's Net Worth
See More Headlines

IVTY Stock Analysis - Frequently Asked Questions

Invuity, Inc. (NASDAQ:IVTY) released its quarterly earnings data on Thursday, August, 2nd. The medical instruments supplier reported ($0.37) EPS for the quarter, topping analysts' consensus estimates of ($0.47) by $0.10. The medical instruments supplier had revenue of $10.50 million for the quarter, compared to the consensus estimate of $10.73 million.

Invuity (IVTY) raised $48 million in an initial public offering on the week of June 15th 2015. The company issued 4,000,000 shares at $12.00 per share. Piper Jaffray, Leerink Partners and Stifel served as the underwriters for the IPO and William Blair was co-manager.

Based on aggregate information from My MarketBeat watchlists, some other companies that Invuity investors own include Cornerstone Strategic Investment Fund (CLM), Allena Pharmaceuticals (ALNA), Madrigal Pharmaceuticals (MDGL), Mondi (MNDI), Protalix BioTherapeutics (PLX), SELLAS Life Sciences Group (SLS) and Spero Therapeutics (SPRO).

Company Calendar

Last Earnings
8/02/2018
Today
7/09/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Surgical & Medical Instruments
Sub-Industry
N/A
Current Symbol
NASDAQ:IVTY
CIK
1393020
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Price / Book
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

This page (NASDAQ:IVTY) was last updated on 7/9/2025 by MarketBeat.com Staff
From Our Partners